| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8738708 | International Journal of Antimicrobial Agents | 2018 | 18 Pages |
Abstract
Our data indicate that moxifloxacin combined with rifampin is as clinically effective as levofloxacin/rifampin for early acute PJI caused by MSSA.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Marjan Wouthuyzen-Bakker, Eduard Tornero, Laura Morata, Prashant V. Nannan Panday, Paul C. Jutte, Guillem Bori, Greetje A. Kampinga, Alex Soriano,